Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 1 5Phase NA 3Phase 2/3 1

Status

Completed 2Unknown 1

Sponsor Class

NIH 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 3Prostatic Hyperplasia 1Neoplasms 1

Interventions

Radiosurgery 45Magnetic Resonance Spectroscopy 41Standard of Care 27Radiotherapy 27Exercise 27Brachytherapy 21Early Intervention, Educational 20Surveys and Questionnaires 18Multiparametric Magnetic Resonance Imaging 17Magnetic Resonance Imaging 16Androgen Antagonists 16Blood Specimen Collection 15Interviews as Topic 14Radiotherapy, Intensity-Modulated 13Methods 13Therapeutics 12Psychiatric Rehabilitation 12Educational Status 12Biopsy 12Specimen Handling 10Resistance Training 10Prostatectomy 9Diet Therapy 9Counseling 9gallium 68 PSMA-11 8Radiation 8Proton Therapy 8Practice Guidelines as Topic 8High-Intensity Interval Training 7Electroporation 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Prostatic Neoplasms × Lycopene × Clear all
NCT00322114 2013-09-20

Lycopene in Preventing Prostate Cancer in Healthy Participants

National Cancer Institute (NCI)

Phase NA Unknown
150 enrolled
Genitourinary

Prostatic Neoplasms

NCT00416390 2013-09-20

Lycopene in Treating Patients With Prostate Cancer or Benign Prostatic Hyperplasia

National Cancer Institute (NCI)

Phase NA Completed
120 enrolled
Genitourinary

Neoplasms, Prostatic Hyperplasia, Prostatic Neoplasms

NCT00042731 2012-09-24

Isoflavones & Lycopene in Localized Prostate Ca:Prior to Radical Prostatectomy

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Completed
79 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡